Stay updated on DANNOAC-AF: Atrial Fibrillation Clinical Trial
Sign up to get notified when there's something new on the DANNOAC-AF: Atrial Fibrillation Clinical Trial page.

Latest updates to the DANNOAC-AF: Atrial Fibrillation Clinical Trial page
- Check4 days agoChange DetectedThe page revision appears to be a routine update to the last modified timestamp with no changes to core study content or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference2%

- Check40 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

- Check54 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; no substantive changes to core content (pricing, stock, or time-slot data), and only a minor UI change is the removal of the 'Back to Top' link.SummaryDifference0.1%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations in Denmark, as well as new pharmaceutical compounds related to anticoagulants. Notably, previous entries for certain anticoagulants have been removed.SummaryDifference4%

Stay in the know with updates to DANNOAC-AF: Atrial Fibrillation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DANNOAC-AF: Atrial Fibrillation Clinical Trial page.